Skip to main content
ACTU
NASDAQ Life Sciences

Actuate Beats on Q3 Loss Per Share but Cash Falls to $2.1M With Going-Concern Doubt

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.285
Mkt Cap
$15.692M
52W Low
$0.283
52W High
$7.9
52W Position info
0.8% above low
Off High info
96% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

ACTU is trading near its 52-week low of $0.283 (0.8% above the low).

Summary

Actuate posted a Q3 adjusted loss of 14 cents a share, better than the 17-cent loss three analysts expected, on zero revenue as anticipated. The reported net loss was $3.42 million. The beat is cosmetic: the company closed the quarter with $2.1 million in cash and explicit going-concern doubt, leaning on the October offering that netted $11.76 million after the over-allotment was exercised November 13. That capital raise came at $0.71 per two shares plus a warrant, and the stock has since slid to about $0.29 — down 62% this quarter and 95.2% this year — leaving it under a Nasdaq minimum bid price notice received October 28 with until April 26, 2027 to regain compliance. The analyst consensus remains 'buy' with a $12 median target, but that rating predates the dilution and the collapse in the share price.

At the time of this announcement, ACTU was trading at $0.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $0.28 to $7.90. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ACTU - Latest Insights

ACTU
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2853
Real-time Price: $0.300 info
Change: +$0.0147 (+5%) info
Market Cap: $15.692M info
ACTU
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3351
Real-time Price: $0.300 info
Change: -$0.0351 (-10%) info
Market Cap: $15.692M info
ACTU
Oct 28, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3833
Real-time Price: $0.300 info
Change: -$0.0833 (-22%) info
Market Cap: $15.692M info
ACTU
Oct 28, 2026, 8:00 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.370
Real-time Price: $0.300 info
Change: -$0.070 (-19%) info
Market Cap: $15.692M info
ACTU
Oct 27, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.4279
Real-time Price: $0.300 info
Change: -$0.1279 (-30%) info
Market Cap: $15.692M info